Engineer · R&D chemist · Founder · Investor

Marieme Sane

I work where biological mechanisms, product systems, and company formation become one problem.

Electrical and computer engineering taught me to model dependencies. R&D chemistry made those dependencies physical: ingredients, dose, stability, evidence, and scale. Founding companies made them consequential. I now bring that accumulated judgment to building and investing in biology-first consumer health.

Engineering

Electrical, computer, and complex systems

Chemistry

Ingredients, formulation, and product development

Building

Companies, platforms, and founder infrastructure

Investing

Biology-first consumer health at pre-seed

Current work

Building the intelligence and infrastructure around better consumer-health companies.

A technical operating lens

A credible product is a connected system.

The claim, ingredient, dose, delivery system, manufacturing process, cost structure, and evidence all have to agree.

How I evaluate a consumer health company

Start with the mechanism. Follow the dependencies.

01

Start with the claim

Work backwards from the promise to the ingredient, dose, delivery system and duration required for it to be honest.

02

Dose, not ingredient

Interrogate percentage, form, pH and whether the formula matches the evidence behind the claim.

03

Cost at real volume

Rebuild the bill of materials around contracted tiers, packaging, freight, quality control, yield loss and actual minimums.

04

Find the weak link

Surface single-source actives, seasonal botanicals, poor documentation and the cost of supplier failure.

05

Survive the line

Test stability, shelf life, packaging compatibility and whether good bench science remains intact at scale.

06

See exposure early

Align claims, substantiation and manufacturing practice before a launch or regulatory letter makes correction expensive.

07

Match the purchase cycle

Make product duration, time-to-effect and repeat purchase economics support one another.

08

Make proof the asset

Build for a buyer who has learned not to believe the label. Evidence is part of the product and the marketing.

The Earthkind system

Better information changes what gets funded—and what gets built.

From builder to investor

The disciplines changed. The method did not.

Engineering taught me to trace how failure moves through a system. Chemistry made that dependency physical: formulation, sourcing, stability, manufacture.

Building JKH Naturals and IONCELL / TRUO Health added the founder’s constraint—technical coherence has to survive capital, regulation, and the economics of a company. Earthkind is the synthesis: a fund and studio that shapes biology-first companies before their earliest decisions harden.

Foundational training in electrical and computer engineering, extended through MIT xPRO’s Architecture of Complex Systems and Harvard University coursework in healthcare delivery, measurement, health equity, and care quality.

Investment lens

Physical products. Biology first.

Pre-seed and seed across women’s life-stage biology, beauty, personal care, supplements, wellness, and consumer health—including hardware where the biology demands it.

Thesis is necessary, not sufficient. I look for revenue per customer that can carry a real business, and a founder who can answer a formulation question without leaving the room.

Not investing in digital health, care delivery, or therapeutics.

Get in touch

Start with the actual product question.

For founders working through formulation, evidence, sourcing, or manufacturing decisions—and investors who need a technically grounded second view.

Explore consulting